库尔库明和皮佩林组合在患有败血症的重症患者的治疗效果:一项随机双盲受控试验
相关实验视频
Updated: Jun 16, 2025

11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
54.8K
Babak Alikiaii1, Narges Khatib1, Mohaddeseh Badpeyma2,3
1Anesthesia and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Trials
|June 13, 2025
概括
黄素-皮佩林补充剂在重症败血症患者中显示出好处,改善炎症标志物和某些实验室值. 这种短期干预对败血症管理中的关键指标产生了积极影响.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 败血症是一种危及生命的器官功能障碍,原因是宿主对感染的反应不平衡.
- 这是一个重要的全球健康问题,死亡率高,特别是在重症监护室 (ICU) 患者中.
- 库尔库以其抗炎和抗氧化特性而闻名,目前正在研究其在败血症中的潜在治疗作用.
研究的目的:
- 为了评估黄素-皮佩林补充剂在被诊断为败血症的重症患者的疗效.
- 评估黄素-皮佩林对败血症患者临床,实验室和生物化学参数的影响.
主要方法:
- 一个双盲,随机对照试验 (RCT) 涉及在ICU的66名败血症患者.
- 参与者每天接受黄素-皮佩林片 (500毫克黄素,5毫克皮佩林) 或安慰剂,持续7天.
- 用治疗意向方法分析了临床和实验室数据.
主要成果:
- 库尔库明-皮佩林显著降低了总胆红素,直接胆红素,pH值,C反应蛋白,红细胞沉积率和血小板数量.
- 干预组的红细胞计数,血红蛋白和血红素显著减少.
- 平均体质血红蛋白和平均体质血红蛋白度在黄素-皮佩林组显著更高.
结论:
- 短期的黄素-皮佩林补充剂在严重病的败血症患者中对特定的炎症和实验室标志物产生有益影响.
- 这些发现表明黄素-皮佩林在治疗败血症相关并发症方面可能发挥作用.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Pneumonia IV: Management
312
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
312
Chronic Pancreatitis II: Collaborative Care
78
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
78
Pneumonia III: Complications and Assessment
191
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
191

